Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.3873
-0.0354 (-8.37%)
At close: Oct 2, 2026, 4:00 PM EDT
0.3825
-0.0048 (-1.24%)
After-hours: Oct 2, 2026, 7:55 PM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $7.71 million as of October 2, 2026. Its market cap has decreased by -69.18% in one year.
Market Cap
7.71M
Enterprise Value
19.74M
1-Year Change
-69.18%
Ranking
Category
Stock Price
$0.39
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $7.71M, a decrease of -92.41%. That is a compound annual growth rate of -29.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 7.71M | -95.38% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 9.85M |
| Aprea Therapeutics | 9.71M |
| CytoMed Therapeutics | 9.70M |
| Senti Biosciences Holdings | 9.66M |
| Traws Pharma | 9.33M |
| FibroBiologics | 9.18M |
| Immuron | 9.01M |
| Alzamend Neuro | 8.66M |